Zomedica Corp. (NYSE:ZOM) has a beta value of 0.27 and has seen 46,337,733 shares traded in the last trading session. The company, currently valued at $1.03 Billion, closed the last trade at $1.06 per share which meant it gained $0.04 on the day or 3.92% during that session. The ZOM stock price is -174.53% off its 52-week high price of $2.91 and 94.06% above the 52-week low of $0.063. If we look at the company’s 10-day average daily trading volume, we find that it stood at 45.2 Million shares traded. The 3-month trading volume is 161.23 Million shares.
The consensus among analysts is that Zomedica Corp. (ZOM) is a Buy stock at the moment, with a recommendation rating of 2. None of the analysts rate the stock as a Sell, while none rate it as Overweight. None out of 1 have rated it as a Hold, with 1 advising it as a Buy. None have rated the stock as Underweight. The expected earnings per share for the stock is $0.
Zomedica Corp. (NYSE:ZOM) trade information
Sporting 3.92% in the green in last session, the stock has traded in the green over the last five days, with the highest price hit on Tuesday, Apr 27 when the ZOM stock price touched $1.3 or saw a rise of 18.46%. Year-to-date, Zomedica Corp. shares have moved 359.67%, while the 5-day performance has seen it change 12.37%. Over the past 30 days, the shares of Zomedica Corp. (NYSE:ZOM) have changed -35.37%. Short interest in the company has seen 63.92 Million shares shorted with days to cover at 0.4.
Wall Street analysts have a consensus price target for the stock at $1.2, which means that the shares’ value could jump 13.21% from current levels. The projected low price target is $1.2 while the price target rests at a high of $1.2. In that case, then, we find that the current price level is +13.21% off the targeted high while a plunge would see the stock lose 13.21% from current levels.
Zomedica Corp. (ZOM) estimates and forecasts
If we evaluate the company’s growth over the last 5-year and for the next 5-year period, we find that annual earnings growth was +8.9% over the past 5 years. Earnings growth for 2021 is a modest +75.1%.
Zomedica Corp. (NYSE:ZOM)’s Major holders
Insiders own 2.65% of the company shares, while shares held by institutions stand at 7.33% with a share float percentage of 7.53%. Investors are also buoyed by the number of investors in a company, with Zomedica Corp. having a total of 58 institutions that hold shares in the company. The top two institutional holders are Vanguard Group Inc. (The) with over 19.34 Million shares worth more than $4.46 Million. As of December 30, 2020, Vanguard Group Inc. (The) held 17.9% of shares outstanding.
The other major institutional holder is Cambridge Investment Research Advisors Inc., with the holding of over 12.25 Million shares as of December 30, 2020. The firm’s total holdings are worth over $2.83 Million and represent 11.34% of shares outstanding.
Also the top two Mutual Funds that are holding company’s shares are Vanguard Total Stock Market Index Fund and Vanguard Extended Market Index Fund. As of December 30, 2020, the former fund manager holds about 10.63% shares in the company for having 11486155 shares of worth $2.65 Million while later fund manager owns 6.72 Million shares of worth $1.55 Million as of December 30, 2020, which makes it owner of about 6.22% of company’s outstanding stock.